Pratik Multani
Chief Tech/Sci/R&D Officer presso ORIC PHARMACEUTICALS, INC.
Patrimonio netto: 683 478 $ in data 31/03/2024
Profilo
Pratik S.
Multani is currently an Independent Director at Chimerix, Inc. and Erasca, Inc. He is also a Principal at the American Board of Internal Medicine.
In addition, he serves as the Chief Medical Officer at Oric Pharmaceuticals, Inc. Dr. Multani previously held positions as a Senior Director-Medical Research & Development at Biogen, Inc. and as a Vice President-Clinical Development at Kalypsys, Inc. He also served as the Chief Medical Officer at Kanisa Pharmaceuticals, Inc. and Ignyta, Inc. Dr. Multani has an undergraduate degree from Yale University, a doctorate from Harvard Medical School, and a graduate degree from Harvard T.H.
Chan School of Public Health.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ERASCA, INC.
0.11% | 01/01/2024 | 172 866 ( 0.11% ) | 356 104 $ | 31/03/2024 |
ORIC PHARMACEUTICALS INC
0.04% | 02/01/2024 | 23 809 ( 0.04% ) | 327 374 $ | 31/03/2024 |
CHIMERIX, INC.
-.--% | 09/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Pratik Multani
| Società | Posizione | Inizio |
|---|---|---|
| ERASCA, INC. | Director/Board Member | 01/07/2018 |
| CHIMERIX, INC. | Director/Board Member | 24/02/2020 |
| ORIC PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2018 |
American Board of Internal Medicine
 American Board of Internal Medicine Miscellaneous Commercial ServicesCommercial Services The American Board of Internal Medicine operates as a self-appointed physician evaluation organization. The private company is based in Philadelphia, PA. The CEO of the company is Richard J. Baron. | Corporate Officer/Principal | - |
Precedenti posizioni note di Pratik Multani
| Società | Posizione | Fine |
|---|---|---|
| IGNYTA INC | Chief Tech/Sci/R&D Officer | 01/01/2017 |
| FATE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Kalypsys, Inc.
 Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Kalypsys, Inc. discovered and developed novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases. The firm advanced its proprietary lead program, a novel, non-corticosteroid small molecule formulated for intranasal delivery, into clinical proof of concept studies. The company was founded by Pratik Shah, Jeremy S. Caldwell, Randall W. King, Kevin D. Lustig, Peter G. Schultz and Robert Downs in 2001 and was headquartered in Solana Beach, CA. | Chief Tech/Sci/R&D Officer | 01/03/2009 |
Kanisa Pharmaceuticals, Inc.
 Kanisa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kanisa Pharmaceuticals, Inc. develops pharmaceuticals and provides medical services. The company develops drugs for diagnosis and treatment of cancer. It was founded by David A. Socks and is located in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/01/2009 |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Corporate Officer/Principal | - |
Formazione di Pratik Multani
| Yale University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| BIOGEN INC. | Health Technology |
| CHIMERIX, INC. | Health Technology |
| FATE THERAPEUTICS, INC. | Health Technology |
| ORIC PHARMACEUTICALS, INC. | Health Technology |
| ERASCA, INC. | Health Technology |
| Aziende private | 7 |
|---|---|
Kalypsys, Inc.
Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Kalypsys, Inc. discovered and developed novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases. The firm advanced its proprietary lead program, a novel, non-corticosteroid small molecule formulated for intranasal delivery, into clinical proof of concept studies. The company was founded by Pratik Shah, Jeremy S. Caldwell, Randall W. King, Kevin D. Lustig, Peter G. Schultz and Robert Downs in 2001 and was headquartered in Solana Beach, CA. | Health Technology |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Health Technology |
Kanisa Pharmaceuticals, Inc.
Kanisa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kanisa Pharmaceuticals, Inc. develops pharmaceuticals and provides medical services. The company develops drugs for diagnosis and treatment of cancer. It was founded by David A. Socks and is located in San Diego, CA. | Health Technology |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
American Board of Internal Medicine
American Board of Internal Medicine Miscellaneous Commercial ServicesCommercial Services The American Board of Internal Medicine operates as a self-appointed physician evaluation organization. The private company is based in Philadelphia, PA. The CEO of the company is Richard J. Baron. | Commercial Services |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Ignyta, Inc. operates as a medicine biotechnology company. The firm engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. The company was founded by Jonathan E. Lim on September 13, 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Pratik Multani
